Delivery Order SPE2DB20D3103-SPE2DB22FP8M9
Award Date
9/12/22
Potential Completion Date
9/13/22
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award ID SPE2DX15D3201|SPE2DX24F3H1X was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,618.98 firm fixed-price delivery order is for the NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML pharmaceutical product. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $1,214.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of NEUPOGEN 300 MCG/ML VIALML, a medical product, with a firm fixed price and an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,465.01 firm-fixed-price delivery order is for the supply of Neupogen 300 mcg/mL vials, a medication used to treat certain types of cancer and other medical conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the supply of NEUPOGEN 300 MCG/ML medication, at a firm fixed price of $33,705.51. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, does not have any set-aside designation for this award. The contract is a delivery order issued under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,739.66 firm-fixed-price delivery order is for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty medication. The award is not associated with a set-aside program and has an ultimate completion date of November 10, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,089.43 Firm Fixed Price delivery order is for the supply of Neupogen 300 mcg/mL vials, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of September 26, 2022 and does not include any set-aside requirements, indicating it was competitively awarded....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,258.62, is a delivery order for NEUPOGEN 300 MCG/0.5 ML SYR 0.5ML, a specialty medication. There was no set-aside designation, indicating this was a full and open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award is for the delivery of Neupogen 480 mcg/0.8 mL syringes to the Defense Logistics Agency (DLA). The $2,128.75 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,526.58 delivery order is for the supply of Neupogen 480 mcg/0.8 ml syringes. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $94,464.49 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA that runs through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...